Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer
NCT00855998 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2010-06-03
Summary
This study aimed to compare the activity of Thymidine Kinase 1 in serum of two groups of woman at high and normal risk for breast/ovary cancer.
Conditions
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2010-03-31
- Completion
- 2011-03-31
Countries
- Israel
Study Locations
More Related Trials
-
Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel
NCT00159003 ·Status: COMPLETED
-
A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women
NCT00858078 ·Status: COMPLETED
-
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
NCT01390597 ·Status: COMPLETED
-
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
NCT01034033 ·Status: RECRUITING
-
Hereditary Risk Factors for Thyroid Cancer
NCT02747888 ·Status: RECRUITING ·Phase: NA
-
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)
NCT01167842 ·Status: COMPLETED
-
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families
NCT03119285 ·Status: COMPLETED
-
Family History Study on Cancer Risk
NCT04145388 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Molecular Markers in Thyroid Cancer
NCT00598364 ·Status: COMPLETED
-
Markers for Predicting Risk of Breast Cancer in Women of Different Races
NCT02574546 ·Status: WITHDRAWN
-
Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients
NCT04222465 ·Status: COMPLETED
-
Identifying and Caring for Individuals With Inherited Cancer Syndrome
NCT04494945 ·Status: RECRUITING ·Phase: NA
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
NCT05587439 ·Status: RECRUITING
-
Clinical Significance of Germline BRCA Mutations
NCT00579488 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnosing Thyroid Cancer Using a Blood Test
NCT01586520 ·Status: COMPLETED
-
A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration
NCT06564428 ·Status: RECRUITING
-
The Registration Program of BRCA1/2 Gene
NCT02593435 ·Status: UNKNOWN
-
A Gene Hunting Study for Familial Papillary Thyroid Cancer
NCT02776969 ·Status: ACTIVE_NOT_RECRUITING
-
Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.
NCT04965649 ·Status: UNKNOWN
-
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
NCT00985699 ·Status: COMPLETED
-
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
NCT03762733 ·Status: ENROLLING_BY_INVITATION
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
NCT01441089 ·Status: RECRUITING